CVS Health stock is trading -23.89% below its average target price of $79.45 after marking a 2.9% during today's morning session. Analysts are giving the Large-Cap Pharmaceutical Retail company an average rating of buy and target prices ranging from $67.0 to $95.0 per share.
The stock has a very low short interest at 1.1%, and a short ratio of 1.97. The company's insiders own 1.08% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 87.5% of CVS Health's shares being owned by this investor type.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-03-31 | Vanguard Group Inc | 9% | 118,335,394 | $7,155,741,419 |
| 2025-03-31 | Blackrock Inc. | 9% | 112,593,476 | $6,808,527,631 |
| 2025-03-31 | Dodge & Cox Inc | 6% | 73,459,122 | $4,442,073,197 |
| 2025-03-31 | Capital World Investors | 5% | 68,398,405 | $4,136,051,633 |
| 2025-03-31 | State Street Corporation | 5% | 57,988,171 | $3,506,544,771 |
| 2025-03-31 | FMR, LLC | 2% | 30,893,511 | $1,868,130,647 |
| 2025-03-31 | Geode Capital Management, LLC | 2% | 27,959,409 | $1,690,705,496 |
| 2025-03-31 | Capital International Investors | 2% | 26,187,658 | $1,583,567,711 |
| 2025-03-31 | JPMORGAN CHASE & CO | 2% | 23,436,358 | $1,417,196,596 |
| 2025-03-31 | Invesco Ltd. | 2% | 20,413,853 | $1,234,425,715 |
Besides an analyst consensus of strong upside potential, other market factors point to there being positive market sentiment on CVS Health.
